With cervical cancer, slow growth cancer affecting the cervix – the lower part of the uterus that connects to the vagina – is an important health problem for women in India. Mainly caused by human papillomavirus (HPV), a sexually transmitted current infection, cervical cancer often develops during the years after precancerous changes in cervical cells.

India, which houses more than 511 million women aged 15 and over, faces an alarming burden on this disease. Each year, around 123,907 women receive a diagnosis of cervical cancer and 77,348 succumb to it, making it the second most common cancer in Indian women. Uterus cervical cancer is often difficult to detect in its beginnings because it may not show notable symptoms.

When symptoms appear, they can be subtle and may resemble those of other conditions. The first current signs include abnormal bleeding between menstrual periods or after menopause, heavier or longer menstrual periods, pelvic pain or lower back and pain during sex. Women can also undergo vaginal bleeding after intercourse, doubles or pelvic exams, as well as changes in vaginal flows, such as a stronger odor or a color change.

As cancer progresses, more serious symptoms can develop, including blood in urine, bone fractures, urination or stools, fatigue, swelling of the legs and pain, serious back pain and unexplained weight loss. The treatment of cervical cancer depends on the stage of the disease, the overall health of the patient and other individual factors.

In the early stages, surgery is often the first treatment option, which can involve the elimination of the collar (hysterectomy) or, in some cases, just the tumor or the part of the pass (conization). Radiotherapy, which uses high energy beams to target and destroy cancer cells, can be used in combination with surgery or as primary treatment for more advanced stages.

In some cases, chemotherapy containing platinum, which uses drugs to kill or stop the growth of cancer cells, is combined with radiotherapy for increased efficiency, especially for advanced or advanced stadium cancers. Immunotherapy helps the immune system to recognize and attack cancer cells and can be used for locally advanced cervical cancers in combination with chemotherapy and radiotherapy.

In advanced / recurrent cervical cancers, targeted chemotherapy ± bevacizumab therapy focuses on specific abnormalities in cancer cells ± immunotherapy can be used. For patients with advanced disease for those who are not eligible for chemotherapy and who have pd-l1 uterus cancer, monotherapy immunotherapy can also be used.

Other treatment options for advanced or metastatic cervix include tisotumab vedotin. For patients whose tumors are HER2-Post (IHC 3 or 2), the Luxe Can trastuzumab can also be taken into account. When healing or control of the disease is not possible, palliative care is provided to manage the symptoms and improve the quality of life of the patient. The treatment plans are generally personalized, often involving a combination of these therapies.

Source

https://timesofindia.indiatimes.com/life-style/health-fitness/health-news/the-connection-between-lifestyle-choices-and-cervical-cancer/articleshow/118451391.cms

Lifestyle Choices and Cervical Cancer Risk: What You Can Do